Aaron Michael Zigler's Legal Cases (4)

Litigation

Carr v. Tillery, 2010 WL 1963398 (S.D.Ill. May 17, 2010).

May 17, 2010

OUTCOME: Case dismissed. Award of $635,000 in sanctions against plaintiff

In 2006, Mr. Zigler began serving as counsel to the firm and its membership in defense of litigation stemming from the firm’s restructuring in 2003. This litigation resulted in eight judgments in favor ... of his clients that were affirmed in three separate appeals and the issuance of an anti-suit injunction prohibiting further litigation against the firm or its employees.

Class action

Parker v. Sears, Roebuck & Co., Case No.: 04-L-716 (Ill.Cir.Ct. Jan. 16, 2008)

Jan 16, 2008

OUTCOME: $544,500.000.00 settlement

Korein Tillery acted as lead counsel in this case against Sears involving allegations that Sears sold and set-up gas and electric ranges throughout the United States without installing anti-tip safety ... devices, which prevent ranges from tipping over and severely burning or injuring unsuspecting consumers. In January, 2008 the Court granted final approval of a settlement which provides complete relief by requiring Sears to install anti-tip brackets for the class as well as requiring the installation of such brackets in the future. The settlement is valued at more than $544,500,000.

Class action

Hoormann v. SmithKline Beecham Corp, 2007 WL 1591510 (Ill.Cir.Ct. May 17, 2007)

May 17, 2007

OUTCOME: $63,800,000.00 Settlement

In July 2004, Korein Tillery sued SmithKline Beecham on behalf of a nationwide class of purchasers alleging that GlaxoSmithKline promoted Paxil® and Paxil CRTM for prescription to children and adolesce ... nts despite having actual knowledge that these drugs exposed children and adolescents to dangerous side effects while failing to treat their symptoms. Following three years of litigation, Korein Tillery obtained a settlement that established a $63.8 million fund to reimburse class members 100% of their out-of-pocket expenses.

Class action

Prather v. Pfizer Inc., 02-L-480 (Ill.Cir.Ct. Dec. 2, 2004)

Dec 02, 2004

OUTCOME: $60,000,000.00 settlement

Following the withdrawal of the anti-diabetes drug Rezulin® from the market, Korein Tillery filed suit against Pfizer and Warner-Lambert, alleging that the defendants engaged in unfair business conduct ... relating to their pricing of Rezulin®. The success of this theory changed the landscape of pharmaceutical litigation. The resulting settlement, finalized 2005, established a fund of $60 million, representing an 85% recovery for claimants and a $20 million cy pres award benefiting diabetes research. Prather v. Pfizer Inc., 02-L-480 (Ill.Cir.Ct. Dec. 2, 2004).

Transform legal challenges into solutions.

Connect now to review your situation.

The Avvo Rating explained

The Avvo Rating explained